PUBLISHED-SEQUENCE ANTIBODY · SC-PSA-0589

Rovelizumab antibody

LFA-1 integrin alphaL-beta2 / CD11a-CD18

Available by inquiry

Rovelizumab is a research antibody reference targeting LFA-1 integrin alphaL-beta2 / CD11a-CD18. Pure and fluorescently conjugated formats are available by inquiry.

Catalog number
SC-PSA-0589
Target
LFA-1 integrin alphaL-beta2 / CD11a-CD18
Available formats
Pure or fluorescently conjugated
Research use
For research use only

Product information

Available labeling options

Pure · Biotin · BV421 · V450 · V500 · AF488 · PerCP-Cy5.5 · PE · AF594 · PE-Cy5 · PE-Cy7 · APC · AF700 · APC-Cy7

Tell us the intended application, amount and preferred label. Final configuration and delivery are confirmed in the quotation.

PUBLIC REFERENCE

Reference source

IUPHAR/BPS ligand 9598

View reference ↗
START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact us
Rovelizumab Antibody (LFA-1 integrin alphaL-beta2 / CD11a-CD18) | StellaCyte